Sai Parenteral's Share Price
Free Demat with Zero AMC*
+ Free 1st Year AMC
Summary
The stock has recorded a trading volume of 62,220 shares,. Its Average Traded Price (ATP) is ₹506.90, while the Last Traded Quantity at the Last Traded Price (LTQ@LTP) is 1 @ ₹502.15.
Sai Parenteral's has an upper circuit limit of ₹607.10 and a lower circuit limit of ₹404.80. The total value traded stands at ₹3.15 CR, and the delivery percentage for the day is 51.48%.
The stock is currently traded with a market lot size of 1. Sai Parenteral's also offers a dividend yield of 0%.
Sai Parenteral's Share Price Chart
Sai Parenteral's Share Key Metrics
Volume
62220.00
Market Cap
2218.46 CR
LTQ@LTP
1@502.15
ATP
506.9
Var Margin
14.72 %
Circuit Range
404.8-607.1
Delivery %
51.48 %
Value
3.15 CR
ASM/GSM
No
Market Lot
1
Sai Parenteral's Resistance and Support
Pivot 507.13
Resistance
First Resistance
512.86
Second Resistance
519.78
Third Resistance
525.51
Support
First Support
500.21
Second Support
494.48
Third Support
487.56
Sai Parenteral's Corporate Actions
| Date | Agenda |
|---|---|
| 2026-11-01 | Quarterly Results |
| 2026-08-11 | Quarterly Results |
| 2026-05-23 | Audited Results & Others |
| 2026-04-20 | Others |
Sai Parenteral's News
Sai Parenterals Ltd - 544742 - Announcement under Regulation 30 (LODR)-Press Release / Media Release
Sai Parenterals reported Q2 FY27 cons. revenue of Rs.196.1 crores, up 9% QoQ, and net profit of Rs.10.5 crores, up 33% QoQ. The company completed the acquisition of 60% stakes in Saicriti Pharma and Prathyak Laboratories. Additionally, its subsidiary Noumed renewed an Australian OTC supply agreement valued at Rs.204 crores.
Nov 01 2026 18:18:07
Sai Parenterals Ltd - 544742 - Board Meeting Outcome for Outcome Of Board Meeting Held On 1St November, 2026
Sai Parenterals reported Q2 FY27 cons. revenue of ₹198.64 crores and net profit of ₹10.51 crores. The company acquired the remaining 25% stake in SP Analytics and completed a 60% acquisition of Saicriti Pharma.
Nov 01 2026 14:51:58
Sai Parenterals Ltd - 544742 - Board Meeting Intimation for Declaration Of Unaudited Financial Results Of The Quarter And Half Year Ended 30Th September, 2026.
Sai Parenteral's board is scheduled to meet on 01 November 2026. The meeting will consider financial results for the quarter ended September 2026. Additional business items may be discussed with the permission of the Chair.
Oct 27 2026 10:44:36
Sai Parenteral's Management
| Name | Position |
|---|---|
| Anil Kumar Karusala | Chairman & Managing Director |
| Vijitha Gorrepati | Whole Time Director |
Sai Parenteral's Similar Stocks
Hikal Ltd.
223.60
-0.92 (0.41%)
Dishman Carbogen Amcis Ltd.
174.10
-0.90 (0.51%)
Fredun Pharmaceuticals Ltd.
1527.30
32.70 (2.19%)
Dr Agarwals Eye Hospital Ltd.
6025.50
171.50 (2.93%)
Sakar Healthcare Ltd.
1072.30
-3.40 (0.32%)
Panacea Biotec Ltd.
361.50
7.80 (2.21%)
Beta Drugs Ltd.
1838.50
-32.50 (1.74%)
Indoco Remedies Ltd.
228.32
8.81 (4.01%)
Windlas Biotech Ltd.
1013.20
14.85 (1.49%)
Hester Biosciences Ltd.
2332.10
-11.30 (0.48%)
Sai Parenteral's FAQs
Open Your Free
Demat Account Now!
AMC for First Year
Auto Square Off Charges
+ Free 1st Year AMC
13 Lakh+ Clients
Expert-Backed
Premium Tools

Open Your Free
Demat Account Now!
AMC For First Year
Account Opening Fee
+ Free 1st Year AMC
13 Lakh+ Clients
Expert-Backed
Premium Tools
Invest in SAIPARENT
Account Opening Fee AMC for 1st Year Auto Square Off Charges Call & Trade
+ Free 1st Year AMC